查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1363334

生命科学 BPO 市场规模、份额和趋势分析报告：2023-2030 年按服务、地区和细分市场分類的趋势

Life Sciences BPO Market Size, Share & Trends Analysis Report By Services (Pharmaceutical Outsourcing, Medical Devices Outsourcing, Contract Sales And Marketing Outsourcing, Others), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 275 Pages | 商品交期: 2-10个工作天内

价格

生命科学 BPO 市场成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球生命科学BPO市场规模预计将达到8,275亿美元，预测期内年复合成长率为9.3%。

药物开发、临床前研究、临床试验和上市后监督成本上升、专利悬崖上升、产品平臺增加和法规限制是推动市场的主要要素。製药和生物技术产业在研发部门投入大量资金，并不断推出新的分子、设备和治疗方法。药物药物研发的各个阶段，包括药物发现、临床前测试和临床试验，都需要大量的资金、技术和人力资源。

外包供应商正在扩大其产品和服务范围，以满足行业不断增长的需求，并瞄准利基领域以实现长期成长和盈利。综合考虑这些趋势，生命领域外包市场预计将在预测期内扩大。在 COVID-19大流行期间，许多外包供应商扩大了现有的製造和研究设施，以满足对 COVID-19 疫苗和诊断不断增长的需求。大流行后，CDMO 正在实施类似的策略来支持未来的药品需求。例如，2022 年 4 月，Aenova 集团投资 1,000 万欧元开发一座新设施，用于生产高活性药物。

预计市场相关人员采取此类策略将对市场有利。人们对降低药品和医疗设备的製造和开发成本的需求日益增长。外包製造、研究和行销服务可以为製药和医疗设备公司节省成本和时间。预计这将对市场产生积极影响。近年来，CRO 和 CDMO 之间的併购有所增加。对临床服务的需求不断增长，以及对专业服务提供者提高对核心能力的关注的需求不断增长，要素将推动併购交易的发生。

生命科学 BPO 市场报告亮点

  • 併购交易的增加扩大了 CRO 和 CDMO 的全球影响力，并提高了它们提供端到端服务的能力。这种趋势的持续预计将为市场带来显着的好处。
  • 由于全球疫苗接种活动的扩大，COVID-19 的罹患率显着下降。
  • 因此，CRO 和 CDMO 目前正专注于开发治疗高负担癌症和其他疾病的药物。
  • 例如，2022年4月，Labcorp将与Xcell Biosciences合作，协助该公司开发细胞和基因疗法来治疗癌症、帕金森氏症和其他罕见疾病。
  • 鑑于基因疗法在治疗癌症和其他罕见疾病方面的高效性，CDMO 的此类倡议可能会使市场受益。
  • 由于医疗设备设计的复杂性，预计 2023 年至 2030 年医疗设备领域的年复合成长率最快。
  • 全球医疗设备认证法规结构更加严格，进一步增加了对医疗设备外包服务的需求。
  • 由于存在大量提供具有成本效益的 BPO 服务的 CRO，亚太地区在 2022 年占据了最大的收入份额。

目录

第1章调查方法和范围

第2章执行摘要

第3章生命科学 BPO 市场变数、趋势与范围

  • 市场体系预测
    • 母市场预测
    • 相关/附随市场预测
  • 普及和成长预测图
  • 市场动态
    • 市场促进因素分析
    • 市场抑制因素分析
  • 生命科学 BPO 市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章生命科学 BPO：按服务进行估算和趋势分析

  • 生命科学 BPO 市场：重点
  • 生命科学 BPO 市场：2022 年和 2030 年趋势和市场占有率分析
  • 医药外包
    • 合约製造市场
    • 受託研究机构
  • 医疗设备外包
    • 合约製造外包
    • 受託研究机构
  • 合约销售和市场外包
  • 其他的

第5章生命科学 BPO 市场：区域估计与趋势分析

  • 区域预测
  • 按地区分類的生命科学 BPO 市场：要点
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第6章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • Atos SE
    • Boehringer Ingelheim International GmbH
    • Catalent, Inc
    • Labcorp Drug Development
    • Genpact
    • ICON plc
    • Infosys Limited
    • IBM
    • Lonza
    • Parexel
    • IQVIA Inc
Product Code: 978-1-68038-959-3

Life Sciences BPO Market Growth & Trends:

The global life sciences BPO market size is expected to reach USD 827.5 billion by 2030, registering a CAGR of 9.3% over the forecast years, according to a new report by Grand View Research, Inc.. The rising costs of drug development; pre-clinical and clinical trials; and post-marketing surveillance; a rise in the patent cliff; a growing product pipeline; and regulatory constraints are some of the major factors driving the market. The pharmaceutical and biotech industries invest heavily in the R&D sector to continuously introduce new molecules, devices, and treatments. The different stages of drug development, such as drug discovery, pre-clinical studies, and clinical trials, require huge financial, technological, and human resources.

To cater to the growing needs of the industry, the outsourcing vendors are expanding their product and service offerings and they are targeting niche areas for long-term growth and profitability. Altogether, these trends are expected to boost the life sciences outsourcing market over the forecast period. During the COVID-19 pandemic, a significant number of outsourcing providers expanded their existing manufacturing and research facilities to meet the growing demand for COVID-19 vaccines and diagnostics. Even post-pandemic, CDMOs are practicing similar strategies to support the future demand for pharmaceuticals. For instance, in April 2022, Aenova Group developed a new facility for manufacturing highly potent drugs with an investment of EUR 10 million.

The adoption of such strategies by the market players is expected to be profitable for the market. There has been a rising demand to reduce the cost of manufacturing and development of drugs and medical devices. Outsourcing manufacturing, research, and marketing services provide pharmaceutical and medical device companies with cost- and time-saving benefits. This is expected to have a positive impact on the market. Over the years, mergers and acquisition deals between CROs and CDMOs have increased. The rising demand for clinical services and the growing need for specialized service providers to improve the focus on their core competencies are some of the factors that are expected to drive the incidence of M&A deals.

Life Sciences BPOMarket Report Highlights:

  • The increasing number of M&A transactions has broadened the global reach and improved the capabilities of CROs and CDMOs to provide end-to-end services; a continuation of this trend is expected to benefit the market significantly
  • COVID-19 incidence has decreased significantly as a result of a growing global vaccination campaign
  • Owing to this, the CRO and CDMO are now refocusing on developing drugs for oncology and other diseases owing to their high burden
  • For instance, in April 2022, Labcorp collaborated with Xcell Biosciences to support the company in developing cell and gene therapies for treating cancer, Parkinson's, and other rare diseases
  • Such initiatives by the CDMOs are likely to profit the market owing to the high effectiveness of gene therapy in treating cancer and other rare diseases
  • The medical device segment is expected to register the fastest CAGR from 2023 to 2030 due to the complexities associated with medical device designing
  • The strict regulatory framework for medical device approval globally has further contributed to the demand for medical device outsourcing services
  • Asia Pacific held the largest revenue share in 2022 due to the presence of a significant number of CROs providing cost-effective BPO services

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Services
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Services outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Life Sciences BPO Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Life Sciences BPO Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic Landscape

Chapter 4. Life Sciences BPO: Service Estimates & Trend Analysis

  • 4.1. Life Sciences BPO Market: Key Takeaways
  • 4.2. Life Sciences BPO Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Pharmaceutical Outsourcing
    • 4.3.1. Pharmaceutical outsourcing market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.3.2. Contract manufacturing market
      • 4.3.2.1. Contract manufacturing market estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.3.2.2. API
      • 4.3.2.2.1. API estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.3.2.3. Finished dose form
      • 4.3.2.3.1. Finished dose form estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.3.2.4. Packaging
      • 4.3.2.4.1. Packaging estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.3.3. Contract research organizations
      • 4.3.3.1. Contract research Organizations estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.3.3.2. Drug discovery
      • 4.3.3.2.1. Drug discovery estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.3.3.3. Preclinical studies
      • 4.3.3.3.1. Preclinical studies estimate and forecasts, 2018 to 2030 (USD Billion)
      • 4.3.3.4. Clinical Trial Studies
      • 4.3.3.4.1. Clinical trial studies estimate and forecasts, 2018 to 2030 (USD Billion)
      • 4.3.3.5. Regulatory services
      • 4.3.3.5.1. Regulatory services estimate and forecasts, 2018 to 2030 (USD Billion)
      • 4.3.3.6. Pharmacovigilance
      • 4.3.3.6.1. Pharmacovigilance estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.4. Medical Devices Outsourcing
    • 4.4.1. Medical devices outsourcing market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.4.2. Contract manufacturing outsourcing
      • 4.4.2.1. Contract manufacturing outsourcing estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.4.2.2. Electronic manufacturing services
      • 4.4.2.2.1. Electronic manufacturing services estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.4.2.3. Finished goods
      • 4.4.2.3.1. Finished goods estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.4.2.4. Raw materials/components
      • 4.4.2.4.1. Raw materials/components estimate and forecasts, 2018 to 2030 (USD Billion)
    • 4.4.3. Contract research organizations
      • 4.4.3.1. Contract research Organizations estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.4.3.2. Regulatory consulting services
      • 4.4.3.2.1. Regulatory consulting services estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.4.3.3. Product design and development services
      • 4.4.3.3.1. Product design and development services estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.4.3.4. Product testing services
      • 4.4.3.4.1. Product testing services estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.4.3.5. Product implementation services
      • 4.4.3.5.1. Product implementation services estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.4.3.6. Product upgrade services
      • 4.4.3.6.1. Product upgrade services estimates and forecasts, 2018 to 2030 (USD Billion)
      • 4.4.3.7. Product maintenance services
      • 4.4.3.7.1. Product maintenance services estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.5. Contract Sales & Market Outsourcing
    • 4.5.1. Contract sales & market outsourcing market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.6. Others
    • 4.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 5. Life Sciences BPO Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Outlook
  • 5.2. Life Sciences BPO Market by Region: Key Takeaways
  • 5.3. North America
    • 5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 5.3.2. U.S.
      • 5.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 5.3.3. Canada
      • 5.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 5.4. Europe
    • 5.4.1. UK
      • 5.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 5.4.2. Germany
      • 5.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 5.4.3. France
      • 5.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 5.4.4. Italy
      • 5.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 5.4.5. Spain
      • 5.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 5.4.6. Sweden
      • 5.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 5.4.7. Norway
      • 5.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 5.4.8. Denmark
      • 5.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 5.5.2. China
      • 5.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 5.5.3. India
      • 5.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 5.5.4. Australia
      • 5.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 5.5.5. Thailand
      • 5.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 5.5.6. South Korea
      • 5.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 5.6. Latin America
    • 5.6.1. Brazil
      • 5.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 5.6.2. Mexico
      • 5.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 5.6.3. Argentina
      • 5.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 5.7. MEA
    • 5.7.1. Saudi Arabia
      • 5.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 5.7.2. South Africa
      • 5.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 5.7.3. UAE
      • 5.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 5.7.4. Kuwait
      • 5.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Market Participant Categorization
    • 6.2.1. Atos SE
      • 6.2.1.1. Company overview
      • 6.2.1.2. Financial performance
      • 6.2.1.3. Product benchmarking
      • 6.2.1.4. Strategic Initiatives
    • 6.2.2. Boehringer Ingelheim International GmbH
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. Catalent, Inc
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. Labcorp Drug Development
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. Genpact
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. ICON plc
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Infosys Limited
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. IBM
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives
    • 6.2.9. Lonza
      • 6.2.9.1. Company overview
      • 6.2.9.2. Financial performance
      • 6.2.9.3. Product benchmarking
      • 6.2.9.4. Strategic initiatives
    • 6.2.10. Parexel
      • 6.2.10.1. Company overview
      • 6.2.10.2. Financial performance
      • 6.2.10.3. Product benchmarking
      • 6.2.10.4. Strategic initiatives
    • 6.2.11. IQVIA Inc
      • 6.2.11.1. Company overview
      • 6.2.11.2. Financial performance
      • 6.2.11.3. Product benchmarking
      • 6.2.11.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America life sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 3 North America life sciences BPO market, by region, 2018 - 2030 (USD Billion)
  • Table 4 U.S. life sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 5 Canada Life Sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 6 Europe life sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 7 Europe life sciences BPO market, by region, 2018 - 2030 (USD Billion)
  • Table 8 Germany life sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 9 UK life sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 10 France life sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 11 Italy life sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 12 Spain life sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 13 Sweden life sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 14 Norway Life Sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 15 Denmark life sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 16 Asia Pacific life sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 17 Asia Pacific life sciences BPO market, by region, 2018 - 2030 (USD Billion)
  • Table 18 China Life Sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 19 Japan Life Sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 20 India life sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 21 Australia life sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 22 Thailand Life Sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 23 South Korea life sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 24 Latin America life sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 25 Latin America life sciences BPO market, by region, 2018 - 2030 (USD Billion)
  • Table 26 Brazil life sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 27 Mexico Life Sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 28 Argentina life sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 29 Middle East and Africa life sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 30 Middle East and Africa life sciences BPO market, by region, 2018 - 2030 (USD Billion)
  • Table 31 South Africa life sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 32 Saudi Arabia Life Sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 33 UAE life sciences BPO market, by services, 2018 - 2030 (USD Billion)
  • Table 34 Kuwait Life Sciences BPO market, by services, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Microneedle drug delivery systems: Market outlook
  • Fig. 9 Microneedle drug delivery systems: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Life sciences BPO market driver impact
  • Fig. 15 Life sciences BPO market restraint impact
  • Fig. 16 Life sciences BPO market strategic initiatives analysis
  • Fig. 17 Life sciences BPO market: Services movement analysis
  • Fig. 18 Life sciences BPO market: Services outlook and key takeaways
  • Fig. 19 Pharmaceutical outsourcing market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 20 Contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 21 API market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 22 Finished dose form market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 23 Packaging market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 24 Contract research organizations market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 25 Drug discovery market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 26 Preclinical studies market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 27 Clinical trial studies market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 28 Regulatory services market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 29 Pharmacovigilance market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 30 Medical devices outsourcing market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 31 Contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 32 Electronic manufacturing services market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 33 Finished goods market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 34 Raw materials/components market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 35 Contract research organizations manufacturing market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 36 Regulatory consulting services market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 37 Product design and development services market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 38 Product testing services market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 39 Product implementation services market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 40 Product upgrade services market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 41 Product maintenance services market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 42 Contract sales & market outsourcing market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 43 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 44 Global life sciences BPO market: Regional movement analysis
  • Fig. 45 Global life sciences BPO market: Regional outlook and key takeaways
  • Fig. 46 North America market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 47 U.S. market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 48 Canada market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 49 Europe market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 50 UK market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 51 Germany market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 52 France market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 53 Italy market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 54 Spain market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 55 Sweden market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 56 Norway market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 57 Denmark market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 58 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 59 Japan market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 60 China market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 61 India market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 62 Australia market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 63 Thailand market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 64 South Korea market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 65 Latin America market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 66 Brazil market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 67 Mexico market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 68 Argentina market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 69 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 70 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 71 South Africa market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 72 UAE market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 73 Kuwait market estimates and forecasts, 2018 - 2030 (USD Billion)